In the last trading session, 1,829,346 Immunovant, Inc. (NASDAQ:IMVT) shares changed hands as the company’s beta touched 0. With the company’s per share price at $11.23 changed hands at $0.09 or 0.01% during last session, the market valuation stood at $1.1 Billion. IMVT’s last price was a discount, traded about -378.63% off its 52-week high of $53.75. The share price had its 52-week low at $9.22, which suggests the last value was 17.9% up since then. When we look at Immunovant, Inc.’s average trading volume, we note the 10-day average is 956.63 Million shares, with the 3-month average coming to 1.15 Million.
Immunovant, Inc. (NASDAQ:IMVT) trade information
Instantly IMVT was in green as seen at the end of in last trading. With action 0.81%, the performance over the past five days has been green. The jump to weekly highs of $11.30 on Friday, Jun 18 added 0.62% to the stock’s daily price. The company’s shares are showing year-to-date downside of -0.76%, with the 5-day performance at 0.05% in the green. However, in the 30-day time frame, Immunovant, Inc. (NASDAQ:IMVT) is -0.27% down. Looking at the short shares, we see there were 5.54 Million shares sold at short interest cover period of 4.82 days.
Immunovant, Inc. (IMVT) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 0%. The 2021 estimates are for Immunovant, Inc. earnings to increase by 20.3%, but the outlook for the next 5-year period is at 0% per year.
Immunovant, Inc. (NASDAQ:IMVT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 60.9% of Immunovant, Inc. shares while 41.57% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 106.31%. There are 190 institutions holding the Immunovant, Inc. stock share, with RTW Investments LP the top institutional holder. As of Mar 30, 2021, the company held 6.49% of the shares, roughly 6.36 Million IMVT shares worth $101.96 Million.
Vanguard Group, Inc. (The) holds the second largest percentage of outstanding shares, with 4.08% or 4Million shares worth $64.11 Million as of Mar 30, 2021.
Among Mutual Funds, the top two as of Apr 29, 2021 were SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Mutual Fund Ser Tr-Eventide Healthcare & Life Sciences Fund. With 3027411 shares estimated at $47.47 Million under it, the former controlled 3.09% of total outstanding shares. On the other hand, Mutual Fund Ser Tr-Eventide Healthcare & Life Sciences Fund held about 2.52% of the shares, roughly 2.47 Million shares worth around $39.67 Million.